Literature DB >> 3284611

Targeting of cytotoxic cells with heterocrosslinked antibodies.

D M Segal1, J R Wunderlich.   

Abstract

Mesh：

Year:  1988        PMID： 3284611     DOI： 10.3109/07357908809077031

Source DB:  PubMed          Journal:  Cancer Invest        ISSN： 0735-7907            Impact factor:   2.176


× No keyword cloud information.
  6 in total

1.  Bispecific-monoclonal-antibody-directed lysis of ovarian carcinoma cells by activated human T lymphocytes.

Authors:  S A Möller; R A Reisfeld
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Chimeric T cell receptor which incorporates the anti-tumour specificity of a monoclonal antibody with the cytolytic activity of T cells: a model system for immunotherapeutical approach.

Authors:  Z Eshhar; G Gross
Journal:  Br J Cancer Suppl       Date:  1990-07

3.  Gene transfer by retrovirus-derived shuttle vectors in the generation of murine bispecific monoclonal antibodies.

Authors:  L B DeMonte; P Nistico; R Tecce; P Dellabona; M Momo; A Anichini; M Mariani; P G Natali; F Malavasi
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

4.  Cell retargeting by bispecific monoclonal antibodies. Evidence of bypass of intratumor susceptibility to cell lysis in human melanoma.

Authors:  P Nisticò; R Mortarini; L B De Monte; A Mazzocchi; M Mariani; F Malavasi; G Parmiani; P G Natali; A Anichini
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

5.  A strategy for evaluating lymphokine activation and novel monoclonal antibodies in antibody-dependent cell-mediated cytotoxicity and effector cell retargeting assays.

Authors:  R P Junghans
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

Review 6.  Biology of natural killer cells.

Authors:  G Trinchieri
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.